Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Replicel Life Sciences Inc
V.RP
Alternate Symbol(s):
REPCF
Technology
Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair...
restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RP)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on Jun 30, 2022 12:16pm
RE:RE:Annual report
We have to Live with the fact that it is all about RCH-01 the Trial should be completed in end of 2022 good to See, Lee got his 240.000$ compensation
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jun 30, 2022 11:20am
RE:2021 Financials
This was the last tweet of any meaningful information from Replicel on March 18th (3 1/2 months ago): "We are nearly finished preparations on an Early Adopter Program for Key Opinion Leaders in
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jun 29, 2022 10:35am
2021 Financials
Well there you have it. The Financials and an Update all in one. I just spent the last half hour reading it and must admit it paints a very alarming picture. In a nutshell RCS-01, RCT-01 are
...more
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Comment by
MetzGER
on Jun 29, 2022 7:14am
RE:Annual report
Wow Jamie MacKay also enlarged his position (14,5 %shares!!) Name of Shareholder No. of Common Shares Owned Percentage of Outstanding Common Shares
...more
(12)
•••
MetzGER
X
View Profile
View Bullboard History
Post by
MetzGER
on Jun 29, 2022 6:23am
Annual report
https://sec.report/Document/0001062993-22-015611/
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jun 28, 2022 11:34am
Lift Off
Get ready for lift off. I think today or tomorrow we will hear that they have submitted the 2021 Financials. That will remove the MCTO. Once that is done we should see the Update. &
...more
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jun 27, 2022 4:22pm
Who ?
In a week that we are expecting an update who would sell 8,500 f-ing shares at $.11 at the end of the day ? Nice going you should be very proud of yourself.
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Jun 27, 2022 3:36pm
RE:RE:RE:RE:RE:RE:This Week
I'm really not that hopeful, after all these years they've promised so much and delivered absolutely nothing, it's very disappointing!
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Jun 26, 2022 10:22pm
RE:RE:RE:RE:RE:This Week
Sry, not buy YOFOTO...but buy their stake
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Jun 26, 2022 10:22pm
RE:RE:RE:RE:This Week
Overall cautiously optimistic...we've been excited in the past. We all know how that's worked out. I also don't this Shiseido is interested in all of Replicel. They would then have
...more
(4)
•••
Genie29j
X
View Profile
View Bullboard History
Comment by
Genie29j
on Jun 26, 2022 10:20pm
RE:RE:RE:This Week
Your third option seems less plausible- while Replicel may not have held up to their end of the agreement, they still own all of the global patents
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Comment by
Ingiboy
on Jun 26, 2022 7:38pm
RE:RE:This Week
I am definetley betting on good news. I am pretty sure tht the Shiseido Arbitration will go Relpicel's way. if so it could be very big for the company. This could play out in a
...more
(1)
•••
Year3000
X
View Profile
View Bullboard History
Comment by
Year3000
on Jun 26, 2022 4:21pm
RE:This Week
What are you betting on... good news or bad news?
(55)
•••
Ingiboy
X
View Profile
View Bullboard History
Post by
Ingiboy
on Jun 26, 2022 3:01pm
This Week
I think this will be an interesting week. The MCTO will be removed and that should hopefully free up management to update the market on the two most important issues facing Replicel: What is the
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >